Raising the stakes on value-based pricing

Raising the stakes on value-based pricing

Andrew Parece
Life Sciences | Life Sciences Strategy

Andrew Parece and Urs Wiedemann published an article in the April issue of Pharmaceutical Executive. The authors discuss outcomes-based, risk-sharing agreements as one approach to change the dialogue between manufacturers and payers, from price to value. To read the article, click the link below. 

Download PDF